These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7768599)

  • 1. Characterization of the structural elements in lipid A required for binding of a recombinant fragment of bactericidal/permeability-increasing protein rBPI23.
    Gazzano-Santoro H; Parent JB; Conlon PJ; Kasler HG; Tsai CM; Lill-Elghanian DA; Hollingsworth RI
    Infect Immun; 1995 Jun; 63(6):2201-5. PubMed ID: 7768599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide.
    Gazzano-Santoro H; Parent JB; Grinna L; Horwitz A; Parsons T; Theofan G; Elsbach P; Weiss J; Conlon PJ
    Infect Immun; 1992 Nov; 60(11):4754-61. PubMed ID: 1398985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.
    Gazzano-Santoro H; Mészáros K; Birr C; Carroll SF; Theofan G; Horwitz AH; Lim E; Aberle S; Kasler H; Parent JB
    Infect Immun; 1994 Apr; 62(4):1185-91. PubMed ID: 8132325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand.
    Appelmelk BJ; An YQ; Thijs BG; MacLaren DM; de Graaff J
    Infect Immun; 1994 Aug; 62(8):3564-7. PubMed ID: 8039930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leukocyte responses by LPS.
    Mészáros K; Parent JB; Gazzano-Santoro H; Little R; Horwitz A; Parsons T; Theofan G; Grinna L; Weickmann J; Elsbach P
    J Leukoc Biol; 1993 Dec; 54(6):558-63. PubMed ID: 8245707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23).
    Little RG; Kelner DN; Lim E; Burke DJ; Conlon PJ
    J Biol Chem; 1994 Jan; 269(3):1865-72. PubMed ID: 8294435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding specificity of polymyxin B, BPI, LALF, and anti-deep core/lipid a monoclonal antibody to lipopolysaccharide partial structures.
    Kellogg TA; Lazaron V; Wasiluk KR; Dunn DL
    Shock; 2001 Feb; 15(2):124-9. PubMed ID: 11220640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity in lipid A binding ligands: comparison of lipid A monoclonal antibodies with rBPI23.
    Appelmelk BJ; Qing AY; Helmerhorst EJ; Maaskant JJ; Abraham PR; Thijs LG; MacLaren DM
    Prog Clin Biol Res; 1995; 392():453-63. PubMed ID: 8524952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes.
    Heumann D; Gallay P; Betz-Corradin S; Barras C; Baumgartner JD; Glauser MP
    J Infect Dis; 1993 Jun; 167(6):1351-7. PubMed ID: 8501324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of a recombinant amino-terminal fragment of bactericidal/permeability-increasing protein in experimental endotoxemia.
    Kohn FR; Ammons WS; Horwitz A; Grinna L; Theofan G; Weickmann J; Kung AH
    J Infect Dis; 1993 Nov; 168(5):1307-10. PubMed ID: 8228369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of a recombinant N-terminal fragment of bactericidal/permeability increasing protein on endotoxic shock in conscious rabbits.
    Lin Y; Ammons WS; Leach WJ; Kung AH
    Shock; 1994 Nov; 2(5):324-31. PubMed ID: 7743357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
    Capodici C; Chen S; Sidorczyk Z; Elsbach P; Weiss J
    Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human lipopolysaccharide-binding protein potentiates bactericidal activity of human bactericidal/permeability-increasing protein.
    Horwitz AH; Williams RE; Nowakowski G
    Infect Immun; 1995 Feb; 63(2):522-7. PubMed ID: 7822017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant amino-terminal fragment of bactericidal/permeability increasing protein (rBPI23) inhibits soluble CD14-mediated lipopolysaccharide-induced endothelial adherence for human neutrophils.
    Huang K; Conlon PJ; Fishwild DM
    Shock; 1994 Feb; 1(2):81-6. PubMed ID: 7538431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and characterization of cysteine-modified variants of an amino-terminal fragment of bactericidal/permeability-increasing protein.
    Horwitz AH; Leigh SD; Abrahamson S; Gazzano-Santoro H; Liu PS; Williams RE; Carroll SF; Theofan G
    Protein Expr Purif; 1996 Aug; 8(1):28-40. PubMed ID: 8812832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endotoxin in acute inflammation induced by gram-negative bacteria: specific inhibition of lipopolysaccharide-mediated responses with an amino-terminal fragment of bactericidal/permeability-increasing protein.
    Kohn FR; Kung AH
    Infect Immun; 1995 Jan; 63(1):333-9. PubMed ID: 7806373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant amino terminal fragment of bactericidal/permeability-increasing protein prevents hemodynamic responses to endotoxin.
    Ammons WS; Kung AH
    Circ Shock; 1993 Nov; 41(3):176-84. PubMed ID: 8269647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of bactericidal permeability-increasing protein in the treatment of gram-negative pneumonia.
    Kelly CJ; Cech AC; Argenteanu M; Gallagher H; Shou J; Minnard E; Daly JM
    Surgery; 1993 Aug; 114(2):140-6. PubMed ID: 8342120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
    Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recombinant 23-kDa N-terminal fragment of bactericidal/permeability-increasing protein (rBPI23) decreases Escherichia coli-induced mortality and organ injury during immunosuppression-related neutropenia.
    Lechner AJ; Lamprech KE; Johanns CA; Matuschak GM
    Shock; 1995 Oct; 4(4):298-306. PubMed ID: 8564560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.